Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers
Clinical trial NCT02259946 · COMPLETED
Trial details
- NCT number
- NCT02259946
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2006-07-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.